Upgrade to SI Premium - Free Trial

Array Biopharma, Inc. (ARRY) Reports Q2 Loss of 17c/Share

August 8, 2011 4:23 PM
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q2 EPS of ($0.17), $0.10 better than the analyst estimate of ($0.27).

Categories

Earnings